Appeals Court Bars Andrx From Using "Altotocor" Brand Name

Law360, New York (May 28, 2004, 12:00 AM EDT) -- A federal appeals court has ordered a lower court to grant Kos Pharmaceuticals’ request for an injunction against Andrx’s use of the brand name "Altocor" in order to prevent consumer confusion over two similar-sounding anti-cholesterol drugs.

In its 39-page decision in Kos Pharmaceuticals Inc. v. Andrx Corp., a unanimous three-judge panel of the 3rd U.S. Circuit Court of Appeals rejected the novel argument that an injunction was needed to prevent the "serious health risk" of a patient's receiving the wrong prescription but has nonetheless ordered the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.